Agilent Technologies, Inc. (A) vs Thermo Fisher Scientific Inc. (TMO)

Agilent Technologies, Inc. and Thermo Fisher Scientific Inc. are both Diagnostics & Research companies. Thermo Fisher Scientific Inc. is the larger, with a market value of $250.8B against $48.4B — 5.2× the size. Agilent Technologies, Inc. trades at the lower P/E: 33.8× against 35.8×. Agilent Technologies, Inc. grew revenue faster over the last twelve months: 8.60% against 8.27%. Agilent Technologies, Inc. has the higher net margin (19.5% vs 14.9%) and the higher return on invested capital (11.1% vs 6.03%). Both pay a dividend; Agilent Technologies, Inc. yields more (0.59% vs 0.27%). Across the 23 metrics below, Agilent Technologies, Inc. leads on 15 and Thermo Fisher Scientific Inc. on 8.

Valuation

Metric A TMO Diagnostics & Research median
P/E 33.77 35.78 34.52
P/S 6.58 5.31 4.24
P/B 6.58 4.59 3.42
Price to free cash flow 38.20 32.92 33.51
EV/EBITDA 26.37 24.58 23.44
EV/Sales 6.83 6.01 5.18
Earnings yield 2.96% 2.79% (1.50%)
Free cash flow yield 2.62% 3.04% 0.00%

Profitability

Metric A TMO Diagnostics & Research median
Gross margin 53.83% 41.08% 48.32%
Operating margin 22.23% 17.89% (5.68%)
Net margin 19.53% 14.94% (4.10%)
Free cash flow margin 17.19% 16.13% 0.00%
Return on equity 20.97% 13.37% 0.00%
Return on assets 11.00% 6.51% (6.05%)
Return on invested capital 11.07% 6.03% 0.00%

Growth

Metric A TMO Diagnostics & Research median
Revenue growth (TTM) 8.60% 8.27% 8.99%
EPS growth (last fiscal year) 3.16% 7.32% 20.36%
Revenue growth, 5-year CAGR 5.41% 6.70% 7.30%
Net income growth, 5-year CAGR 12.63% 1.01% 0.00%

Health

Metric A TMO Diagnostics & Research median
Debt to equity 0.50 0.71 0.01
Current ratio 2.05 1.81 2.27
Net debt to EBITDA 0.71 2.45 0.68

Dividend

Metric A TMO Diagnostics & Research median
Dividend yield 0.59% 0.27% 0.67%
Payout ratio 0.20 0.10 0.20

Size

Metric A TMO Diagnostics & Research median
Market cap 48.43b 250.82b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack